Clinical evaluation of Pseudomonas hyperimmune globulin.
D000818:Animals; D002056:Burns / Q000150:complications; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007118:Immunoassay; D007074:Immunoglobulin G / Q000008:administration & dosage; D007136:Immunoglobulins / Q000008:administration & dosage*; D007273:Injections, Intramuscular; D051379:Mice; D009504:Neutrophils / Q000032:analysis; D009895:Opsonin Proteins / Q000032:analysis; D011014:Pneumonia / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000254:growth & development; D018805:Sepsis / Q000150:complications / Q000188:drug therapy*; D014946:Wound Infection / Q000150:complications / Q000188:drug therapy
D007074:Immunoglobulin G; D007136:Immunoglobulins; D009895:Opsonin Proteins